MICOT PHARMA-B 02335Hong Kong Stock Exchange

22.0802.47%( -0.560 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
MICOT PHARMA-B (02335) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Market
HKEX Main Board
Listing Date
2026-06-24
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007Q79

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-214.02M79/125

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
王冰 Executive Director
Yu Weiping Executive Director
王梅 Non-Executive Director
游向东 Non-Executive Director
宋高广 Non-Executive Director
王娜祎 Non-Executive Director
相里六续 Independent Non-Executive Director
张文强 Independent Non-Executive Director
王开峰 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-23.

About this page

This page shows MICOT PHARMA-B (02335) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.